Sign in

CIK 0001699382

  • Non-accelerated filer
  • Smaller reporting company

PMV Pharmaceuticals, Inc.

Sign in to watch
Ticker
PMVP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463218129
Phone
+1 609-642-6670
Business address
400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
  1. 3 Insider Initial Statement of Ownership
  2. 4 Exercise or conversion President and CEO acquired 9,000 shares (option exercise)
  3. 4 Open-market sale Director sold 800 shares at $30.15 ($24,120)
  4. 4 Open-market sale Director sold 14,619 shares at an average $30.09 ($439,821)
  5. 4 Open-market sale Director sold 7,461 shares at an average $30.06 ($224,251)
  6. 4 Open-market sale Director sold 100 shares at $30.00 ($3,000)
  7. 4 Open-market sale Director sold 3,500 shares at $30.00 ($105,000)
  8. 4 Open-market sale Director sold 711 shares at $30.03 ($21,351)
  9. 4 Open-market sale Director sold 70,828 shares at an average $30.41 ($2,154,007)
  10. 4 Open-market sale Chief Medical Officer sold 100 shares at $30.25 ($3,025)
  11. 4 Open-market sale Chief Medical Officer sold 3,900 shares at $30.25 ($117,975)
  12. 4 Open-market sale Director sold 46,906 shares at an average $30.25 ($1,418,687)
  13. 4 Open-market sale Director sold 58,829 shares at an average $30.45 ($1,791,095)
  14. 4 Open-market sale Director sold 51,854 shares at an average $30.87 ($1,600,944)
  15. 4 Open-market sale Director sold 3,500 shares at $29.50 ($103,250)
  16. 4 Open-market sale Director sold 30,664 shares at an average $33.05 ($1,013,320)
  17. 4 Exercise or conversion President and CEO acquired 5,500 shares (option exercise)
  18. 4 Exercise or conversion COO, CFO acquired 5,000 shares (option exercise)
  19. 4 Open-market sale SVP, Regulatory Affairs and QA sold 2,896 shares at $33.78 ($97,814)
  20. 4 Open-market sale Director sold 80,491 shares at an average $33.89 ($2,727,673)

Page 5 of 10 · 190 filings